Camel Milk and Autoimmune Hepatitis: Immune Modulation & Liver Protection

Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease characterized by the immune system mistakenly attacking hepatocytes, leading to interface hepatitis, fibrosis, and potentially cirrhosis or liver failure if untreated. Current standard therapies rely on immunosuppressants like corticosteroids and azathioprine, which carry significant long-term side effects and fail to restore immune tolerance in many patients. Emerging research suggests camel milk (CM) may offer a complementary nutritional approach by modulating aberrant immune responses, mitigating oxidative stress, and supporting hepatic repair in AIH.

Pathogenesis and Therapeutic Challenges in AIH

AIH pathogenesis involves a breakdown in immune tolerance mechanisms. Genetic predisposition (particularly HLA-DRB1 alleles) combined with environmental triggers leads to dysfunctional regulatory T cells (Tregs), which normally suppress autoreactive CD4+ and CD8+ T cells. This dysfunction permits effector T cells to infiltrate the liver parenchyma, producing pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-17) and activating B cells to generate pathogenic autoantibodies. The resulting inflammation induces oxidative stress, hepatocyte apoptosis, and fibrogenesis. Crucially, current immunosuppressants do not fully correct underlying Treg defects and carry risks like metabolic complications, highlighting the need for adjunctive therapies.

Immunomodulatory Mechanisms of Camel Milk

Camel milk contains bioactive components that may counter AIH-specific immune dysregulation:

1. Lactoferrin (Lf): Abundant in CM (0.22 mg/ml), Lf modulates inflammatory cascades by inhibiting LPS-induced activation of Kupffer cells via TLR4 blockade, reducing TNF-α, IL-6, and IL-1β production. In chronic liver injury models, Lf suppresses Th17 differentiation (a key driver of inflammation in AIH) while promoting Treg expansion, potentially rebalancing the Th17/Treg axis disrupted in AIH. Additionally, Lf exhibits direct antiviral effects against hepatitis-associated viruses by binding viral particles.
2. Immunoglobulins (IgG): CM contains high levels of IgG (1.64 mg/ml)—significantly more than cow’s milk. These immunoglobulins are smaller (1/10th the size of human antibodies), enabling superior tissue penetration and enhanced neutralization of pathogens and autoantigens in the liver. IgG also facilitates opsonization of cellular debris, reducing antigenic triggers for autoreactive B cells.
3. Bioactive Peptides: Proteolytic digestion of CM proteins generates peptides that inhibit angiotensin-I-converting enzyme (ACE), thereby reducing pro-fibrotic signalling in hepatic stellate cells. Peptides from β-casein (65% of CM casein) also exhibit immunosuppressive effects by dampening dendritic cell maturation and antigen presentation.

Table 1: Key Immunomodulatory Components in Camel Milk

Component	Concentration in CM	Mechanism in AIH Context
Lactoferrin	0.22 mg/ml	Inhibits TLR4 signaling; ↑ Treg/↓ Th17 differentiation; antiviral activity
Immunoglobulin G (IgG)	1.64 mg/ml	Neutralizes autoantigens; opsonizes cellular debris; penetrates tissues effectively
β-Casein-derived peptides	N/A	Suppresses dendritic cell maturation; ACE inhibition (anti-fibrotic)

Antioxidant and Anti-inflammatory Protection

Chronic inflammation in AIH generates reactive oxygen species (ROS), causing hepatocyte DNA damage and lipid peroxidation. CM counters this via:

• Vitamin C & Enzymes: CM contains 3–5 times more vitamin C (27.53 mg/L) than cow’s milk, scavenging free radicals (e.g., hydroxyl, peroxyl) and regenerating glutathione. Additionally, CM enzymes like superoxide dismutase (SOD) and catalase directly neutralize superoxide anions and hydrogen peroxide. In alcohol-induced liver injury models, CM significantly lowered hepatic malondialdehyde (MDA)—a lipid peroxidation marker—while boosting SOD and glutathione (GSH) activity.
• Anti-inflammatory Cytokine Shift: CM consumption in murine models reduced pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) while elevating anti-inflammatory IL-10, mirroring effects seen in AIH remission. This shift correlates with histological improvements in inflammation and fibrosis.

Nutritional Support for Hepatic Function

Beyond immunomodulation, CM provides critical nutritional support:

• High-Quality Proteins: CM proteins are rich in essential amino acids (e.g., methionine, cysteine) crucial for glutathione synthesis—the liver’s master antioxidant.
• Bioavailable Minerals: Elevated zinc (↑ vs. cow’s milk) stabilizes cell membranes and inhibits hepatocyte apoptosis, while iron-bound lactoferrin ensures safe iron transport without promoting oxidative stress.
• Low Allergenicity: Unlike cow’s milk, CM lacks β-lactoglobulin and has low αs1-casein, reducing immune triggers in susceptible individuals.

Table 2: Comparative Antioxidant Nutrients in Camel Milk vs. Cow’s Milk

Nutrient/Enzyme	Camel Milk Concentration	Cow’s Milk Concentration	Biological Impact
Vitamin C	27.53 mg/L	5–10 mg/L	Direct ROS scavenging; regenerates reduced glutathione
Lactoferrin	0.22 mg/ml	0.02 mg/ml	Chelates iron; prevents iron-catalyzed ROS formation
Zinc	4.9 mg/L	3.0 mg/L	Cofactor for SOD; stabilizes hepatocyte membranes

Clinical and Research Implications

While human clinical trials in AIH are limited, studies in viral hepatitis and alcoholic liver disease demonstrate CM’s hepatoprotective efficacy. Patients with chronic hepatitis B/C consuming raw CM showed significant reductions in serum ALT, AST, and gamma-glutamyl transferase (GGT) levels—key markers of hepatocellular damage. Histological improvements in inflammation and fibrosis were also noted. For AIH management, CM could serve as:

1. An adjunct to immunosuppressants, potentially lowering corticosteroid doses and mitigating side effects.
2. A maintenance nutrient during remission to prevent flares via sustained immunomodulation.
3. A preventive measure in high-risk individuals (e.g., relatives of AIH patients).

Future research should prioritize randomized controlled trials examining CM’s impact on AIH-specific outcomes (e.g., IgG normalization, histological activity index) and mechanistic studies on CM-derived exosomes or microRNAs regulating Treg function.

Conclusion

Camel milk represents a promising nutritional intervention for AIH by targeting the disease’s immunological core. Its multifaceted actions—rebalancing T-cell responses, quenching oxidative stress, suppressing inflammatory cytokines, and providing hepatoprotective nutrients—address both the causes and consequences of autoimmune liver damage. While not replacing pharmacotherapy, CM offers a low-risk, supportive strategy to enhance disease management and improve patient outcomes. Further clinical validation will solidify its role in integrative hepatology paradigms.

---

Glossary

1. Autoimmune Hepatitis (AIH): A chronic inflammatory liver disease where the immune system erroneously attacks hepatocytes, leading to fibrosis and potential cirrhosis.
2. Lactoferrin: An iron-binding glycoprotein in camel milk with immunomodulatory, antioxidant, and antiviral properties.
3. Regulatory T cells (Tregs): Immune cells that suppress autoreactive lymphocytes; defective in AIH.
4. Th17 Cells: Pro-inflammatory T-cells producing IL-17; implicated in AIH pathogenesis.
5. Immunoglobulin G (IgG): Antibodies in camel milk that neutralize pathogens and autoantigens.

References

1. Althnaian T. Camel milk protectiveness toward multiple liver disorders. Front Nutr. 2022;9:944842. doi:10.3389/fnut.2022.944842 1.
2. Ebaid H et al. The Antioxidant, Anti-Inflammatory and Immunomodulatory Effects of Camel Milk. Front Immunol. 2022;13:855342. doi:10.3389/fimmu.2022.855342 212.
3. Chen Y et al. The progress of autoimmune hepatitis research and future directions. Med (Berlin). 2023;18(1):20230823. doi:10.1515/med-2023-0823 3.
4. Li Y et al. Camel milk ameliorates inflammatory mechanisms in an alcohol-induced liver injury mouse model. Sci Rep. 2021;11:22811. doi:10.1038/s41598-021-02357-1 4.
5. Moustafa A et al. Nutritional, antimicrobial and medicinal properties of Camel’s milk. Saudi J Biol Sci. 2021;28(5):3126–3136. doi:10.1016/j.sjbs.2021.02.057 5.
6. Liberal R et al. Autoimmune hepatitis: Current and future therapies. Hepatol Commun. 2024;8:e0458. doi:10.1097/HC9.0000000000000458 6.
7. Lleo A et al. Dysfunctional Immune Regulation in Autoimmune Hepatitis. Front Immunol. 2021;12:746436. doi:10.3389/fimmu.2021.746436 11.
8. Saeed A et al. An updated comprehensive review of camel milk. Int J Dairy Sci. 2024; [In Press]. doi:10.1016/j.ijfoodsci.2024.05.001 10.